EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Liver Kinase B1 in CD11c + Cells Inhibits Fibrosis in Chronic Pancreatitis via the Oncostatin M Signaling

Wenqing Zhang, Shan Guo, Yu Zhang, He Ren, Ke Lei, Chenyang Zhao, Qian Yu, Hongqing Luo, Yujing Xiao, Xiaoming Feng iD, Xiaoyu Li iD

Advanced Science · 2026-06 · 13 (32)

DOI: 10.1002/advs.75018 ↗

At a glance

Journal article in Advanced Science, published online on 2026-03-30. Written by Wenqing Zhang and 10 co-authors. Institution: Department of Gastroenterology, the Affiliated Hospital of Qingdao University, Qingdao, China. Major MEDLINE topics: Pancreatitis, Chronic, Fibrosis, Oncostatin M, Protein Serine-Threonine Kinases. 55 references. The full text is freely available (open access, CC BY 4.0). Funded by: Natural Science Foundation of China, National Science Fund for Distinguished Young Scholars, Key Program of National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Chronic pancreatitis (CP), characterized by irreversible fibrosis, is a high‐risk factor for pancreatic cancer. Current therapeutic strategies remain inadequate. This study identified a significant increase in CD11c + cells within fibrotic regions of CP patient pancreatic tissues, accompanied by markedly reduced expression of liver kinase B1 (Lkb1) in these cells. Animal experiments confirmed that Lkb1 deletion in CD11c + cells markedly exacerbated pancreatic fibrosis. Further investigation revealed that Lkb1 deletion in CD11c + cells drove the differentiation of monocytes into CD11c + CD206 + mixed‐phenotype macrophages, leading to their accumulation in fibrotic lesions. The CCL2/CCR2 signaling axis was identified as the key pathway mediating the infiltration of these macrophages. Mechanistically, Lkb1 deletion enhanced STAT3 phosphorylation in CD11c + CD206 + macrophages, promoted CCL2 secretion, and thereby promoted more CD11c + CD206 + macrophages to infiltrate. CD11c + CD206 + macrophages activated pancreatic stellate cells (PSCs) via OSM binding to its receptor OSMR, thereby stimulating CCL2 production of PSCs. This recruits additional monocyte‐derived macrophages to sustain PSC activation and exacerbates extracellular matrix (ECM) deposition. Concurrently, neutralization of OSM suppressed CCL2 secretion from PSCs and markedly attenuated pancreatic fibrosis. This study reveals that Lkb1 deletion in CD11c + cells exacerbates CP‐associated fibrosis via the OSM and CCL2/CCR2 axis, thereby presenting a potential therapeutic strategy for CP fibrosis.

Subjects

MeSH terms (MEDLINE)

Pancreatitis, ChronicFibrosisOncostatin MProtein Serine-Threonine KinasesCD11c AntigenAnimalsHumansSignal TransductionMiceMacrophagesPancreatic Stellate CellsAMP-Activated Protein Kinase KinasesPancreasMaleDisease Models, AnimalAMP-Activated Protein Kinases

Author keywords

CCL2/CCR2chronic pancreatitisfibrosisliver kinase B1oncostatin M

Substances

Oncostatin MProtein Serine-Threonine KinasesAMP-Activated Protein Kinase KinasesStk11 protein, mouseCD11c AntigenAMP-Activated Protein Kinases

Authors and institutions

  • Department of Gastroenterology, the Affiliated Hospital of Qingdao University, Qingdao, China.
  • Gastrointestinal Cancer Institute (Pancreatic Disease Institute), the Affiliated Hospital of Qingdao University, Qingdao, China.
  • Tumor Immunology and Cytotherapy of Medical Research Center, Key Laboratory of Pancreatic Disease Clinical Research (Shandong Province), the Affiliated Hospital of Qingdao University, Qingdao, China.
  • Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao, China.
  • T-cell Precision Therapy Lab, Department of Pathology and Pathophysiology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, China.

ORCID profiles: Xiaoming Feng, Xiaoyu Li

Funding

  • Natural Science Foundation of China
  • National Science Fund for Distinguished Young Scholars
  • Key Program of National Natural Science Foundation of China
  • Taishan Young Scholars Program of Shandong Province
  • 2023 Qingdao Technology Benefiting Demonstration Project
  • "Medicine Plus " Joint Research Program of Qingdao University
  • National Natural Science Foundation of China

Cite

APA

Zhang, W., Guo, S., Zhang, Y., Ren, H., Lei, K., Zhao, C., Yu, Q., Luo, H., Xiao, Y., Feng, X., & Li, X. (2026). Liver Kinase B1 in CD11c + Cells Inhibits Fibrosis in Chronic Pancreatitis via the Oncostatin M Signaling. Advanced Science, 13(32). https://doi.org/10.1002/advs.75018

Vancouver

Zhang W, Guo S, Zhang Y, Ren H, Lei K, Zhao C, et al. Liver Kinase B1 in CD11c + Cells Inhibits Fibrosis in Chronic Pancreatitis via the Oncostatin M Signaling. Advanced Science. 2026;13(32). doi:10.1002/advs.75018

BibTeX
@article{Zhang2026,
  author = {Zhang, Wenqing and Guo, Shan and Zhang, Yu and Ren, He and Lei, Ke and Zhao, Chenyang and Yu, Qian and Luo, Hongqing and Xiao, Yujing and Feng, Xiaoming and Li, Xiaoyu},
  title = {Liver Kinase B1 in CD11c + Cells Inhibits Fibrosis in Chronic Pancreatitis via the Oncostatin M Signaling},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {32},
  doi = {10.1002/advs.75018}
}
Start for free →